Literature DB >> 11685971

Surpassing conventional therapies: the role of biologic therapy.

R N Baldassano1.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11685971

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  3 in total

Review 1.  Managing Crohn disease in children and adolescents : focus on tumor necrosis factor antagonists.

Authors:  Shehzad A Saeed; Wallace V Crandall
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

2.  Infliximab as a therapy for non-Crohn's enterocutaneous fistulae.

Authors:  Ravindra S Date; Kanwar Jit Singh Panesar; Paul Neilly
Journal:  Int J Colorectal Dis       Date:  2004-06-03       Impact factor: 2.571

Review 3.  Infliximab therapy in children and adolescents with inflammatory bowel disease.

Authors:  Gabor Veres; Robert N Baldassano; Petar Mamula
Journal:  Drugs       Date:  2007       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.